Article
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
16 Aug 2022
Abstract excerpt
The development of preclinical in vitro models has provided significant progress to the studies of cystic fibrosis (CF), a frequently fatal monogenic disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Numerous cell lines were generated over the last 30 years and they have been instrumental not only in enhancing the understanding of CF pathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
